Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial

BACKGROUND: Although the release of cardiac biomarkers after percutaneous (PCI) or surgical revascularization (CABG) is common, its prognostic significance is not known. Questions remain about the mechanisms and degree of correlation between the release, the volume of myocardial tissue loss, and the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hueb, Whady, Gersh, Bernard J, Rezende, Paulo Cury, Garzillo, Cibele Larrosa, Lima, Eduardo Gomes, Vieira, Ricardo D'Oliveira, Garcia, Rosa Maria Rahmi, Favarato, Desiderio, Segre, Carlos Alexandre W, Pereira, Alexandre Costa, Soares, Paulo Rogério, Ribeiro, Expedito, Lemos, Pedro, Perin, Marco A, Strunz, Célia Cassaro, Dallan, Luis AO, Jatene, Fabio B, Stolf, Noedir AG, Hueb, Alexandre Ciappina, Dias, Ricardo, Gaiotto, Fabio A, da Costa, Leandro Menezes Alves, Oikawa, Fernando Teiichi Costa, de Melo, Rodrigo Morel Vieira, Serrano, Carlos Vicente, de Ávila, Luiz Francisco Rodrigues, Villa, Alexandre Volney, Filho, José Rodrigues Parga, Nomura, César, Ramires, José AF, Filho, Roberto Kalil
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2012
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3468382/
https://ncbi.nlm.nih.gov/pubmed/22898311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-12-65
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares